Skip to main content
. 2021 May 28;118(22):e2104504118. doi: 10.1073/pnas.2104504118

Fig. 2.

Fig. 2.

Mutations and deletions of the hcHLA-I genes in MHC-INEG and MHC-IPOS DLBCL. Genetic lesions affecting B2M and other genes implicated in antigen presentation in 42 MHC-INEG (A) and 32 MHC-IPOS (B) DLBCL primary cases, color-coded according to mutation type. Cross marks indicate germline homozygous HLA-I alleles, where allele-specific LOH cannot be predicted; on the right side, “A” and “B” denote separate alleles (see Materials and Methods and SI Appendix, Tables S2–S4 for details on mutation type).